Immuno-oncology publication spotlight: our top recent peer-reviewed journal articles featuring Fortrea oncologists discussing immuno-oncology drug development

The Fortrea team has over 60 oncologists, many often contribute to immuno-oncology peer-reviewed journal articles. Read the articles here.

Raising the bar: How our Ophthalmology Academy transforms clinical trials

Clinical Trial Site Support Solutions

Through our solutions to support clinical trial sites, we offer flexible resources to bridge gaps in your operations.

Phase I Alzheimer’s Disease

Applying a patient- and site-centric approach in an early Phase I Alzheimer’s Disease study

How Fortrea Mobile Clinical Services (MCS) may improve the patient experience in oncology studies

Case Study highlights Fortea mobile clinical support services in global oncology trials to support investigator sites and patients.

Hybrid protocol: Accelerated success

Efficient FIH hybrid protocol trial design for a biotechnology immunology drug study.

Peer-reviewed journal articles featuring Fortrea oncologists published 2020-2025

The Fortrea team has over 60 oncologists, many often contribute to oncology peer-reviewed journal articles. Read the articles here.

Is it time to go beyond classic design in oncology trials?

This paper discusses how FIH studies with healthy volunteers could open up new possibilities in cancer drug development.